Please login to the form below

Not currently logged in
Email:
Password:

MSI hires Pfizer veteran David Watson

Will specialise in channel strategy at the UK-based consultancy

David Watson, MSI ConsultancyHealthcare consultancy firm the MSI Consultancy has appointed David Watson as senior consultant specialising in channel strategy.

Watson's most recent role was at the US pharma firm Pfizer as commercial director and head of business intelligence, Europe for Pfizer Specialty Care.

He spent more than 20 years at Pfizer in both UK and European roles, including such positions as European commercial operations director, specialist PV business unit and European commercial director, established products / trade strategy.

During his time at Pfizer, he gained experience in channel strategies, leading projects that focused on using alternative routes to market specialty and oncology products.

This experience, along with his understanding of the European market, will help him in his new role, MSI said, where he will work with clients to offer specialised consultancy in different channels strategies.

17th January 2013

From: PME

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics